New anti-tuberculosis agents amongst known drugs
- 20 August 2009
- journal article
- Published by Elsevier in Tuberculosis
- Vol. 89 (5), 364-370
- https://doi.org/10.1016/j.tube.2009.07.002
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expressionMolecular Cancer Therapeutics, 2008
- The Novel Combination of Chlorpromazine and Pentamidine Exerts Synergistic Antiproliferative Effects through Dual Mitotic ActionCancer Research, 2007
- Promising Clinical Efficacy of Streptomycin-Rifampin Combination for Treatment of Buruli Ulcer ( Mycobacterium ulcerans Disease)Antimicrobial Agents and Chemotherapy, 2007
- Worldwide Emergence of Extensively Drug-resistant TuberculosisEmerging Infectious Diseases, 2007
- Pilot Randomized Double-Blind Trial of Treatment ofMycobacterium ulceransDisease (Buruli Ulcer) with Topical Nitrogen OxidesAntimicrobial Agents and Chemotherapy, 2004
- The effects of rifampicin and fluoroquinolones on tubercle bacilli within human macrophagesInternational Journal of Antimicrobial Agents, 2004
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- Effect of long-term primary aerosolized pentamidine prophylaxis on breakthrough Pneumocystis carinii pneumoniaEuropean Respiratory Journal, 1996
- In-vitro activity of seventeen antimicrobial compounds against seven species of mycobacteriaJournal of Antimicrobial Chemotherapy, 1988
- In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosisJournal of Antimicrobial Chemotherapy, 1987